Melanotan 2 (MT-II) Peptide research-grade
Melanotan 2 (MT-II) Peptide
$50.00 Add to cart

Melanotan 2 (MT-II) Peptide

$50.00

Research-grade Melanotan 2 (MT-II) Peptide for laboratory investigation. For Research Use Only. Not for human use.

In stock

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Melanotan 2 (MT-II) Peptide research-grade

Overview

Melanotan 2 (MT-II) Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for Melanotan 2 (MT-II) Peptide

Work involving Melanotan 2 (MT-II) Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Melanotan 2 (MT-II) Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Melanotan 2 (MT-II) Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Melanotan 2 (MT-II) Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Melanotan 2 (MT-II) Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Melanotan 2 (MT-II) Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 19 PubMed records. Displaying 10 per page.

  1. Varshney U et al. (1984). Research subjects metallothionein MT-I and MT-II processed genes [PMID: 6526271]

    Laboratory literature summary: research subjects metallothionein MT-I and MT-II processed genes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Wu JP et al. (2007). Characterization of metallothioneins (MT-I and MT-II) in the yak [PMID: 17121968]

    Laboratory literature summary: Characterization of metallothioneins (MT-I and MT-II) in the yak. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Wessells H et al. (2003). MT-II induces penile erection via brain and spinal mechanisms [PMID: 12851302]

    Laboratory literature summary: MT-II induces penile erection via brain and spinal mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Strader AD et al. (2007). Laboratory research record on Melanotan 2 (MT-II) [PMID: 17567964]

    PubMed laboratory record discussing Melanotan 2 (MT-II) in a research context. Review the full methods and limitations on PubMed; research use only.

  5. Bednarek MA et al. (1999). Structure-function studies on the cyclic peptide MT-II, lactam derivative of… [PMID: 10447101]

    Laboratory literature summary: Structure-function studies on the cyclic peptide MT-II, lactam derivative of alpha-melanotropin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Shrestha YB et al. (2004). Action of MT-II on ghrelin-induced feeding in the paraventricular nucleus of the… [PMID: 15167567]

    Laboratory literature summary: Action of MT-II on ghrelin-induced feeding in the paraventricular nucleus of the hypothalamus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Trivedi P et al. (2003). Exploring the site of anorectic action of peripherally administered synthetic… [PMID: 12834882]

    Laboratory literature summary: Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Testa C et al. (2014). 1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis,… [PMID: 25347033]

    Laboratory literature summary: 1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Cai M et al. (2004). Biological and conformational study of beta-substituted prolines in MT-II template:… [PMID: 15009533]

    Laboratory literature summary: Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to research subjects MC5…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Loney KD et al. (2003). Strain-specific brain metallothionein II (MT-II) gene expression, its ethanol… [PMID: 12658104]

    Laboratory literature summary: Strain-specific brain metallothionein II (MT-II) gene expression, its ethanol responsiveness, and association with ethanol preference in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Ugwu SO et al. (1994). A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II)… [PMID: 7981427]

    Laboratory literature summary: A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Grieco P et al. (2007). Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their… [PMID: 17482720]

    Laboratory literature summary: Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at research subjects…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Lachke SA et al. (2000). Phenotypic switching in Candida glabrata involves phase-specific regulation of the… [PMID: 10639459]

    Laboratory literature summary: Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Grieco P et al. (2003). Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119:… [PMID: 14531843]

    Laboratory literature summary: Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at research subjects…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Seeley RJ et al. (2005). The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity [PMID: 15932932]

    Laboratory literature summary: The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Doedens L et al. (2010). Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor… [PMID: 20496895]

    Laboratory literature summary: Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Giuliano F et al. (2005). The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II)… [PMID: 15967265]

    Laboratory literature summary: The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Vemulapalli R et al. (2001). Activation of central melanocortin receptors by MT-II increases cavernosal pressure in… [PMID: 11739247]

    Laboratory literature summary: Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Scarpace PJ et al. (2003). Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin… [PMID: 12842127]

    Laboratory literature summary: Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is Melanotan 2 peptide?

Melanotan 2 is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH). It is commonly studied in research labs for its interaction with melanocortin receptors and pigmentation-related pathways.

What is Melanotan 2 used for in research?

Melanotan 2 is used in laboratory research to investigate melanocortin system activity, including pigmentation processes and related biological mechanisms. It is not approved for human use.

Is Melanotan 2 (MT-II) Peptide approved or intended for human use?

No. Melanotan 2 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Melanotan 2 (MT-II) Peptide FDA-approved for medical or clinical use?

No. Melanotan 2 is not approved by the U.S. Food and Drug Administration for any medical, cosmetic, or investigational use.

In what form is Melanotan 2 supplied?

Melanotan 2 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research environments.

How should Melanotan 2 be stored?

Store lyophilized peptides sealed in their original vial, protected from light and humidity, at -4°F or colder for long-term stability; refrigeration (~39°F) is acceptable for short-term use.

What vial sizes are available for Melanotan 2?

Melanotan 2 is available in multiple vial sizes (e.g., 5000 IU, 10,000 IU).

Is Melanotan 2 (MT-II) Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only and must not be used for human consumption.

How is Melanotan 2 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

How can I verify Melanotan 2 purity and quality?

Product quality is supported by third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/